These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1172249

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. LSD as an agonist at mesolimbic dopamine receptors.
    Kelly PH, Iversen LL.
    Psychopharmacologia; 1975 Dec 31; 45(2):221-4. PubMed ID: 2943
    [Abstract] [Full Text] [Related]

  • 3. Drug-induced dopaminergic supersensitivity.
    Moore KE, Thornburg JE.
    Adv Neurol; 1975 Dec 31; 9():93-104. PubMed ID: 1146661
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat.
    Pycock C.
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May 31; 298(1):15-22. PubMed ID: 560634
    [Abstract] [Full Text] [Related]

  • 6. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
    Thornburg JE, Moore KE.
    J Pharmacol Exp Ther; 1975 Jan 31; 192(1):42-9. PubMed ID: 1168250
    [Abstract] [Full Text] [Related]

  • 7. Modification of avoidance behavior in 6-hydroxydopamine-treated rats by stimulation of central noradrenergic and dopaminergic receptors.
    Lenard LG, Beer B.
    Pharmacol Biochem Behav; 1975 Jan 31; 3(5):887-93. PubMed ID: 1208631
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of chronic apomorphine on the development of denervation supersensitivity.
    Robin M, Forler C, Palfreyman MG.
    Pharmacol Biochem Behav; 1985 Apr 31; 22(4):547-51. PubMed ID: 3921992
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC, Jenner P, Marsden CD.
    Pharmacol Biochem Behav; 1976 Jun 31; 4(6):661-70. PubMed ID: 981283
    [Abstract] [Full Text] [Related]

  • 13. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 31; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 14. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD, Creese I.
    Adv Neurol; 1975 Mar 31; 9():81-92. PubMed ID: 1170717
    [No Abstract] [Full Text] [Related]

  • 15. Cholinergic-dopaminergic interaction in the striatum: the effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil and d-amphetamine.
    Ladinsky H, Consolo S, Bianchi S, Samanin R, Ghezzi D.
    Brain Res; 1975 Feb 07; 84(2):221-6. PubMed ID: 1111831
    [Abstract] [Full Text] [Related]

  • 16. The effect of cyclo (Leu-Gly) on chemical denervation supersensitivity of dopamine receptors induced by intracerebroventricular injection of 6-hydroxydopamine in mice.
    Ritzmann RF, Bhargava HN.
    Life Sci; 1980 Dec 01; 27(22):2075-80. PubMed ID: 6782403
    [No Abstract] [Full Text] [Related]

  • 17. Aporphines. 16. Action of aporphine alkaloids on locomotor activity in rats with 6-hydroxydopamine lesions of the nucleus accumbens.
    Kelly PH, Miller RJ, Neumeyer JL.
    Eur J Pharmacol; 1976 Jan 01; 35(1):85-92. PubMed ID: 1253829
    [Abstract] [Full Text] [Related]

  • 18. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B, Marsden CD, Naylor RJ, Pycock CJ.
    Brain Res; 1976 Dec 10; 118(1):87-113. PubMed ID: 990957
    [Abstract] [Full Text] [Related]

  • 19. Behavioral quantification of striatal dopaminergic supersensitivity after bilateral 6-hydroxydopamine lesions in the mouse.
    Mandel RJ, Wilcox RE, Randall PK.
    Pharmacol Biochem Behav; 1992 Feb 10; 41(2):343-7. PubMed ID: 1574523
    [Abstract] [Full Text] [Related]

  • 20. Further evidence for the stimulation of rat brain dopamine receptors by ergometrine.
    Woodruff GN, Elkhawad AO, Crossman AR.
    J Pharm Pharmacol; 1974 Jun 10; 26(6):455-6. PubMed ID: 4154992
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.